PCM
CERE

Pentwater Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Pentwater Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,878,719
Closed -$76.8M – 75
2024
Q2 		$76.8M Sell
1,878,719
-341,281
-15% -$14M 0.98% 13
2024
Q1 		$93.8M Buy
2,220,000
+1,120,000
+102% +$47.3M 0.96% 12
2023
Q4 		$46.6M Buy
+1,100,000
New +$46.6M 0.52% 23